Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04080804 |
|---|---|
| Brief Title: | Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer |
| First Submitted : | September 3, 2019 |
| First Submitted that Met QC Criteria : | September 3, 2019 |
| First Posted : | September 6, 2019 |
| Last Update Submitted that Met QC Criteria : | March 31, 2022 |
| Last Update Posted : | April 4, 2022 |